Atherogenic Mechanisms of Electronic Nicotine Delivery Systems
电子尼古丁输送系统的致动脉粥样硬化机制
基本信息
- 批准号:9917380
- 负责人:
- 金额:$ 74.29万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-01-01 至 2023-12-31
- 项目状态:已结题
- 来源:
- 关键词:AcetaldehydeAcroleinAerosolsAffectAldehydesAnimal ModelAnimalsApoptosisArterial Fatty StreakAtherosclerosisBlood VesselsCardiovascular DiseasesCarnosineCellsCessation of lifeCharacteristicsChemicalsChronicChronic DiseaseCigarCigaretteCollagenDataDevicesDipeptidesDiseaseDoseElectronic Nicotine Delivery SystemsElectronic cigaretteEmerging Tobacco ProductsEndotheliumExcisionExposure toFatty acid glycerol estersFormaldehydeGlycerolHumanIn VitroInflammationInflammatoryJUULKnockout MiceLesionLifeLow Density Lipoprotein ReceptorMacrophage ActivationMatrix MetalloproteinasesMeasuresMediatingMicroRNAsMolecularMusMyeloid CellsMyocardial InfarctionNatureNecrosisNicotineNitrosaminesOralPathway interactionsPlayProcessPropylene GlycolsProteinsRiskRoleSignal TransductionSmokeSmokeless TobaccoSmokerSmokingSmooth Muscle MyocytesStrokeSupplementationTestingThromboplastinTimeTobaccoTobacco smokeTobacco useToxic effectToxinTreesUntranslated RNAUrineVegetablesadductair filteralpha-bungarotoxin receptoratherogenesisatherosclerosis riskbasechronic inflammatory diseasecigarette smokecigarette smokingcigarilloscombustible cigarettecombustion productcytokineelectronic hookahelectronic liquidfeedingheart disease riskhookahinsightmacrophagemortality risknoveloverexpressionprematurepreventrecruitresponsesextobacco productstoxicant
项目摘要
Nicotine is an abundant toxicant in various tobacco products including cigarette smoke,
smokeless tobacco, cigars, cigarillos, and hookah. The use of tobacco products increase the risk
for atherosclerosis. Although usage of conventional cigarette has steadily declined over the last
three decades, usage of new and emerging tobacco products and electronic nicotine delivery
systems (ENDS) such as electronic cigarettes (e-cig), e-hookah, and e-cigars has increased
exponentially. ENDS aerosolize a solution known as an “e-liquid” (typically a combination of
propylene glycol, PG, and vegetable glycerol, VG) that contains a small percentage of nicotine.
Although several combustion products and toxins such as CO and tobacco-specific nitrosamines
are non-detectable in ENDS, carbonyls including short-chain toxic aldehydes (acrolein,
formaldehyde, acetaldehyde, etc.) have been detected in e-cig-derived aerosols up to levels
found in tobacco smoke. Our preliminary data suggest that exposure to e-cig or its components,
such as acrolein and nicotine (oral exposure) induce macrophage activation (cytokine formation,
MMP activation, and apoptosis) and exacerbate atherosclerosis. Conversely, quenching of
endogenous aldehydes by feeding with the endogenous dipeptide - carnosine (β-ala-his) or
overexpressing carnosine synthase in macrophages prevents atherosclerosis. Our preliminary
studies also show that chronic exposure to e-cig, nicotine, and acrolein increase the expression
of micro RNA-21 (miR-21) in the aortae of atherogenic mice; and acrolein and nicotine induce
miR-21 in macrophages in culture, presumable as an adaptive response to macrophage
activation. Based on these observations we hypothesize that miR-21 decreases ENDS-induced
atherogenesis by preventing macrophage activation by ENDS-derived aldehydes and nicotine.
To test this hypothesis, we will 1) Examine the effect of e-cig on atherogenesis. In LDL receptor-
null mice exposed to filtered air, varying proportions of propylene glycol (PG):vegetable glycerin
(VG), PG:VG + nicotine, and JUUL-specific e-liquids, we will quantify the time-, dose-, and sex-
dependent changes in atherosclerotic lesion formation. We will examine how ENDS and their
components affect the plaque composition, the nature, and the stability; 2) Delineate the
atherogenic contribution of ENDS-derived aldehydes. We will examine whether quenching of e-
liquid and ENDS-derived aldehydes by oral feeding with carnosine or macrophage-specific
overexpression of carnosine synthase prevents macrophage activation and atherogenesis and
how are these processes regulated by miR-21; 3) Elucidate the atherogenicity of ENDSderived
nicotine. We will probe how ENDS activate macrophage α7nAChR, and how macrophage-specific
deficiency of α7nAChR affects ENDS-induced macrophage activation and atherogenesis. We will
also examine how miR-21 regulates these processes. Overall, the proposed studies will establish
novel animal models of ENDS-induced atherosclerosis, and delineate the underling chemical,
cellular, and molecular mechanisms of toxicity.
尼古丁是包括香烟烟雾在内的各种烟草制品中的大量有毒物质,
无烟烟草、雪茄、小雪茄和水烟。烟草制品的使用增加了风险
治疗动脉粥样硬化尽管传统香烟的使用在过去几年中稳步下降,
三十年来,新的和新兴的烟草产品的使用和电子尼古丁输送
电子烟(e-cig)、电子水烟(e-hookah)和电子雪茄(e-cigars)等电子烟系统(ENDS)的使用量增加。
呈指数级增长。ENDS使被称为“电子液体”的溶液(通常是以下物质的组合)雾化:
丙二醇,PG和植物甘油,VG),其含有小百分比的尼古丁。
虽然一些燃烧产物和毒素,如CO和烟草特有的亚硝胺
在ENDS中是检测不到的,羰基包括短链有毒醛(丙烯醛,
甲醛、乙醛等)在电子烟产生的气溶胶中检测到的含量
在烟草烟雾中发现。我们的初步数据表明,接触电子烟或其成分,
例如丙烯醛和尼古丁(口服暴露)诱导巨噬细胞活化(细胞因子形成,
MMP激活和细胞凋亡)并加剧动脉粥样硬化。相反,
内源性醛通过用内源性二肽-肌肽(β-ala-his)喂养或
巨噬细胞中肌肽合酶的过度表达可预防动脉粥样硬化。我们的初步
研究还表明,长期接触电子烟、尼古丁和丙烯醛会增加
在致动脉粥样硬化小鼠的动脉中的microRNA-21(miR-21)的表达;丙烯醛和尼古丁诱导
培养物中巨噬细胞中的miR-21,推测为对巨噬细胞的适应性反应
activation.基于这些观察结果,我们假设miR-21降低了ENDS诱导的细胞凋亡。
通过防止ENDS衍生的醛和尼古丁激活巨噬细胞来预防动脉粥样硬化。
为了验证这一假设,我们将1)检查电子烟对动脉粥样硬化的影响。在低密度脂蛋白受体-
空小鼠暴露于过滤空气,不同比例的丙二醇(PG):植物甘油
(VG),PG:VG +尼古丁和JUUL特定的电子液体,我们将量化时间,剂量和性别-
动脉粥样硬化病变形成的依赖性变化。我们将研究如何结束和他们的
成分影响菌斑的组成、性质和稳定性; 2)描绘
ENDS衍生的醛类的致动脉粥样硬化作用。我们将研究是否淬火e-
液体和ENDS衍生的醛,通过口服肌肽或巨噬细胞特异性
肌肽合酶的过表达防止巨噬细胞活化和动脉粥样硬化形成,
miR-21如何调控这些过程; 3)阐明ENDS衍生的动脉粥样硬化性,
尼古丁。我们将探讨ENDS如何激活巨噬细胞α 7 nAChR,以及巨噬细胞特异性
α 7 nAChR缺乏影响ENDS诱导的巨噬细胞活化和动脉粥样硬化形成我们将
我们还研究了miR-21如何调节这些过程。总体而言,拟议的研究将建立
ENDS诱导的动脉粥样硬化的新动物模型,并描述了潜在的化学物质,
毒性的细胞和分子机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sanjay Srivastava其他文献
Sanjay Srivastava的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sanjay Srivastava', 18)}}的其他基金
Atherogenic Mechanisms of Electronic Nicotine Delivery Systems
电子尼古丁输送系统的致动脉粥样硬化机制
- 批准号:
10533743 - 财政年份:2020
- 资助金额:
$ 74.29万 - 项目类别:
Atherogenic Mechanisms of Electronic Nicotine Delivery Systems
电子尼古丁输送系统的致动脉粥样硬化机制
- 批准号:
10317034 - 财政年份:2020
- 资助金额:
$ 74.29万 - 项目类别:
Atherogenic Mechanisms of Electronic Nicotine Delivery Systems
电子尼古丁输送系统的致动脉粥样硬化机制
- 批准号:
10082463 - 财政年份:2020
- 资助金额:
$ 74.29万 - 项目类别:
Project 2 - Molecular and Cellular Mechanisms of Cardiometabolic Toxicity of VOCs
项目2——VOCs心脏代谢毒性的分子和细胞机制
- 批准号:
10693804 - 财政年份:2017
- 资助金额:
$ 74.29万 - 项目类别:
Environmental Exposure and Cardiometabolic Disease
环境暴露与心血管代谢疾病
- 批准号:
10354688 - 财政年份:2017
- 资助金额:
$ 74.29万 - 项目类别:
KC Donnelly Externship–Promotion of Translational/Transdisciplinary Efforts in Graduate & Post-Doctoral Research
KC Donnelly 实习 — 促进研究生的转化/跨学科努力
- 批准号:
10382018 - 财政年份:2017
- 资助金额:
$ 74.29万 - 项目类别:
Environmental Exposure and Cardiometabolic Disease
环境暴露与心血管代谢疾病
- 批准号:
9904675 - 财政年份:2017
- 资助金额:
$ 74.29万 - 项目类别:
相似国自然基金
Acrolein调控耳蜗核神经元-胶质细胞网络参与感音神经性耳聋发病机制的研究
- 批准号:81570922
- 批准年份:2015
- 资助金额:65.0 万元
- 项目类别:面上项目
acrolein在脊髓损伤后慢性疼痛发生发展中的作用及机制研究
- 批准号:81171052
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
相似海外基金
In vivo anti cancer natural product synthesis based on reaction with endogenous acrolein
基于与内源性丙烯醛反应的体内抗癌天然产物合成
- 批准号:
23KJ0944 - 财政年份:2023
- 资助金额:
$ 74.29万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Prodrug Strategy by Diels-Alder Reaction with Cancer-Derived Acrolein
通过与癌症衍生的丙烯醛进行第尔斯-阿尔德反应的前药策略
- 批准号:
23K17971 - 财政年份:2023
- 资助金额:
$ 74.29万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Reactivity of acrolein produced by cancer cells: Application to selective cancer therapy
癌细胞产生的丙烯醛的反应性:在选择性癌症治疗中的应用
- 批准号:
21K05269 - 财政年份:2021
- 资助金额:
$ 74.29万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Resarch on prevention of cyclophosphamide cardiotocity by removing acrolein
去除丙烯醛预防环磷酰胺强心死亡的研究
- 批准号:
20K08232 - 财政年份:2020
- 资助金额:
$ 74.29万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
In vivo Click Reaction of Acrolein: Application to In vivo Synthetic Chemistry and Cancer Imaging
丙烯醛的体内点击反应:在体内合成化学和癌症成像中的应用
- 批准号:
18K14341 - 财政年份:2018
- 资助金额:
$ 74.29万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Glial activation induced by unsaturated aldehyde acrolein in diabetic retinopathy
不饱和醛丙烯醛诱导糖尿病视网膜病变中的胶质细胞活化
- 批准号:
18K09393 - 财政年份:2018
- 资助金额:
$ 74.29万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Mechanism of acrolein generation in diabetic retinopathy
糖尿病视网膜病变中丙烯醛的生成机制
- 批准号:
17K11442 - 财政年份:2017
- 资助金额:
$ 74.29万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of fluorescent probes for acrolein, a product of lipid peroxidation
脂质过氧化产物丙烯醛荧光探针的开发
- 批准号:
17H06580 - 财政年份:2017
- 资助金额:
$ 74.29万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Role of acrolein in the pathogenesis of diabetic retinopathy
丙烯醛在糖尿病视网膜病变发病机制中的作用
- 批准号:
26462657 - 财政年份:2014
- 资助金额:
$ 74.29万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Novel Treatments of Acrolein-induced Cardiotoxicity
丙烯醛引起的心脏毒性的新疗法
- 批准号:
8610016 - 财政年份:2013
- 资助金额:
$ 74.29万 - 项目类别: